TR-298: Dimethyl morpholinophosphoramidate (597-25-1)
Study Results
Chronic Bioassay Level of Evidence
Rats | |
---|---|
View
|
|
View
|
Mice | |
---|---|
View
|
|
View
|
Genetic Toxicology
Mammalian Cell Cytogenetics | |
---|---|
CA | SCE |
|
|
Bacterial Mutagenicity |
---|
View
|
Publications
TR-298
Toxicology and Carcinogenesis Studies of Dimethyl Morpholinophosphoramidate (CASRN 597-25-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity of Dimethyl Morpholinophosphoramidate (597-25-1) in Male F344 Rats Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of Dimethyl Morpholinophosphoramidate (597-25-1) in Female F344 Rats Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of Dimethyl Morpholinophosphoramidate (597-25-1) in Male B6C3F1 Mice Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of Dimethyl Morpholinophosphoramidate (597-25-1) in Female B6C3F1 Mice Exposed via Gavage
Genetic Toxicology Studies
Genetic Toxicity Evaluation of Dimethyl Morpholinophosphoramidate in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 960949
Summary Data
- G06 - Ames Summary Data (128 KB)